（冠心病、高血压病）慢性心力衰竭气阴两虚夹瘀证和阳虚水泛证中医诊疗方案的规范化研究
摘要
目的通过采用中成药物配合西药常规治疗与单纯西药治疗组相对比,对入选的慢性心衰气阴两虚夹瘀证及阳虚水泛证病例进行研究,观察治疗前后病人临床疗效,旨在探讨出治疗气阴两虚夹瘀证及阳虚水泛证慢性心衰的安全有效、简便、实用、利于推广的康复治疗方案。
方法将入选72例病人随机分为两组,其中对照组给予基础常规治疗;治疗组在基础常规治疗基础上,辨证加服中成药物;其中气阴两虚夹瘀证给予生脉饮加血府逐瘀胶囊,阳虚水泛证给予芪苈强心胶囊口服,疗程为1个月。观察两组病人治疗前后临床症状变化、通过心脏超声及心胸比率变化评估心功能变化;采用酶联免疫法检测治疗前后病人血清BNP含量的变化,采用明尼苏达量表估病人生活质量变化;随访3个月,观察病人再住院率及心血管终点事件的发生率(死亡及急性心梗心衰发生率)。
结果1、临床观察结果表明,治疗1组(气阴两虚夹瘀组)总有效率为91.4%,治疗2组(阳虚水泛组)总有效率为91.07%,对照组总有效率为79.21%。两组总有效率及临床显效率经统计学处理均P<0.05,有显著性差异,说明治疗组疗效明显优于对照组。2、治疗前各组病人的血清BNP水平明显升高,并且BNP表达水平与心衰的严重程度正相关,经过治疗心衰症状好转后,病人血清BNP水平明显降低。其中治疗1组、治疗2组血清BNP变化程度较对照组明显。3、通过明尼苏达量表分析,治疗1组及治疗2组生活质量的改善程度明显优于对照组。4、治疗及随访期间治疗2组再住院率共1人次,对照组再住院率4人次,治疗组明显少于对照组。
结论1、采用中药辩证治疗配合西药常规治疗可明显改善慢性心衰病人临床症状,改善病人的心功能,提高病人的生活质量,减少再住院率,优于单纯西药治疗;2、血清BNP作为心衰诊断的敏感性指标,对判定病情、判定疗效及预后的评价具有方向性的指导作用;3、中医药辩证治疗治疗配合西药常规疗法治疗慢性心力衰竭气阴两虚夹瘀证及阳虚水泛证方案行之有效,简便易行,值得进一步推广。
Purpose through the use of Chinese patent medicines with conventional western medicine, western medicine treatment and simple treatment group compared to the selected folder with chronic heart failure Deficiency of Qi and Yin and Yang Stasis Syndrome water pan card case study to observe the clinical efficacy of patients before and after treatment to Discussion on the treatment of both Qi and Yin deficiency and Yang folder Stasis Syndrome water pan card chronic heart failure is safe and effective, simple, practical and conducive to the promotion of the rehabilitation treatment program.
Methods 72 cases of selected patients were randomly divided into two groups, one of the control group given conventional treatment foundation; treatment group at the basis of conventional treatment based on differentiation of Chinese patent medicines to add service; one of Qi and Yin Deficiency Stasis Syndrome folder add ShengmaiYin give blood Zhuyu capsule, Yang Pan-permit water to give stilbazolium Lepidii Qiangxin capsules oral, treatment for a month. Patients were observed changes in clinical symptoms before and after treatment by echocardiography and assessment of heart rate changes in cardiac function changes; By enzyme-linked immunosorbent assay before and after treatment Patient serum BNP concentration changes, the use of the Minnesota Scale for assessing the quality of life of sick Change; 3 month follow-up to observe the patient re-hospitalization rates and the incidence of cardiovascular end point rate (death and acute myocardial infarction heart The incidence of failure).
The results one clinical observation results show that treatment of one group (folder Yin Deficiency blood group) the total effective rate was 91.4%, treatment 2 group (Yang Pan-water group) the total effective rate was 91.07% in the control group the total effective rate was 79.21%. The two groups have a total efficiency and the efficiency of clinical significant statistical processing of P <0.05, there is significant difference on efficacy of the treatment group was superior to the control group. 2, pre-treatment of patients in each group serum BNP levels were significantly elevated, and the expression level of BNP with the severity of heart failure are related, after the treatment of heart failure symptoms improved, patients with BNP levels were significantly lower. One of the treatment of one group, treatment group 2 Change of serum BNP level higher than the control group significantly. 3, through the Minnesota scale analysis, the treatment of one group and treatment group 2 the quality of life improved significantly better than the control group. 4, 3 month follow-up results of the treatment group re-hospitalization rates were 0 views, the control group re-hospitalization rate of 4 million, the treatment group was significantly rare in the control group.
Conclusion 1, the use of traditional Chinese medicine combined with western medicine dialectical conventional therapy can significantly improve the clinical symptoms of chronic heart failure patients, improving the patient's cardiac function, improve the quality of life of patients and reduce re-hospitalization rate, better than western medicine treatment; 2, serum BNP for heart failure diagnosis of the sensitivity of indicators to determine the patient's condition to determine the efficacy and prognostic evaluation of the role of directional guidance. 3, Chinese medicine treatment of the dialectical treatment of western medicine with conventional therapy in chronic heart failure folder Stasis Syndrome of Qi-Yin Deficiency and Yang Pan-water certification programs effective, user-friendly and worthy of further promotion.
方法将入选72例病人随机分为两组,其中对照组给予基础常规治疗;治疗组在基础常规治疗基础上,辨证加服中成药物;其中气阴两虚夹瘀证给予生脉饮加血府逐瘀胶囊,阳虚水泛证给予芪苈强心胶囊口服,疗程为1个月。观察两组病人治疗前后临床症状变化、通过心脏超声及心胸比率变化评估心功能变化;采用酶联免疫法检测治疗前后病人血清BNP含量的变化,采用明尼苏达量表估病人生活质量变化;随访3个月,观察病人再住院率及心血管终点事件的发生率(死亡及急性心梗心衰发生率)。
结果1、临床观察结果表明,治疗1组(气阴两虚夹瘀组)总有效率为91.4%,治疗2组(阳虚水泛组)总有效率为91.07%,对照组总有效率为79.21%。两组总有效率及临床显效率经统计学处理均P<0.05,有显著性差异,说明治疗组疗效明显优于对照组。2、治疗前各组病人的血清BNP水平明显升高,并且BNP表达水平与心衰的严重程度正相关,经过治疗心衰症状好转后,病人血清BNP水平明显降低。其中治疗1组、治疗2组血清BNP变化程度较对照组明显。3、通过明尼苏达量表分析,治疗1组及治疗2组生活质量的改善程度明显优于对照组。4、治疗及随访期间治疗2组再住院率共1人次,对照组再住院率4人次,治疗组明显少于对照组。
结论1、采用中药辩证治疗配合西药常规治疗可明显改善慢性心衰病人临床症状,改善病人的心功能,提高病人的生活质量,减少再住院率,优于单纯西药治疗;2、血清BNP作为心衰诊断的敏感性指标,对判定病情、判定疗效及预后的评价具有方向性的指导作用;3、中医药辩证治疗治疗配合西药常规疗法治疗慢性心力衰竭气阴两虚夹瘀证及阳虚水泛证方案行之有效,简便易行,值得进一步推广。
Purpose through the use of Chinese patent medicines with conventional western medicine, western medicine treatment and simple treatment group compared to the selected folder with chronic heart failure Deficiency of Qi and Yin and Yang Stasis Syndrome water pan card case study to observe the clinical efficacy of patients before and after treatment to Discussion on the treatment of both Qi and Yin deficiency and Yang folder Stasis Syndrome water pan card chronic heart failure is safe and effective, simple, practical and conducive to the promotion of the rehabilitation treatment program.
Methods 72 cases of selected patients were randomly divided into two groups, one of the control group given conventional treatment foundation; treatment group at the basis of conventional treatment based on differentiation of Chinese patent medicines to add service; one of Qi and Yin Deficiency Stasis Syndrome folder add ShengmaiYin give blood Zhuyu capsule, Yang Pan-permit water to give stilbazolium Lepidii Qiangxin capsules oral, treatment for a month. Patients were observed changes in clinical symptoms before and after treatment by echocardiography and assessment of heart rate changes in cardiac function changes; By enzyme-linked immunosorbent assay before and after treatment Patient serum BNP concentration changes, the use of the Minnesota Scale for assessing the quality of life of sick Change; 3 month follow-up to observe the patient re-hospitalization rates and the incidence of cardiovascular end point rate (death and acute myocardial infarction heart The incidence of failure).
The results one clinical observation results show that treatment of one group (folder Yin Deficiency blood group) the total effective rate was 91.4%, treatment 2 group (Yang Pan-water group) the total effective rate was 91.07% in the control group the total effective rate was 79.21%. The two groups have a total efficiency and the efficiency of clinical significant statistical processing of P <0.05, there is significant difference on efficacy of the treatment group was superior to the control group. 2, pre-treatment of patients in each group serum BNP levels were significantly elevated, and the expression level of BNP with the severity of heart failure are related, after the treatment of heart failure symptoms improved, patients with BNP levels were significantly lower. One of the treatment of one group, treatment group 2 Change of serum BNP level higher than the control group significantly. 3, through the Minnesota scale analysis, the treatment of one group and treatment group 2 the quality of life improved significantly better than the control group. 4, 3 month follow-up results of the treatment group re-hospitalization rates were 0 views, the control group re-hospitalization rate of 4 million, the treatment group was significantly rare in the control group.
Conclusion 1, the use of traditional Chinese medicine combined with western medicine dialectical conventional therapy can significantly improve the clinical symptoms of chronic heart failure patients, improving the patient's cardiac function, improve the quality of life of patients and reduce re-hospitalization rate, better than western medicine treatment; 2, serum BNP for heart failure diagnosis of the sensitivity of indicators to determine the patient's condition to determine the efficacy and prognostic evaluation of the role of directional guidance. 3, Chinese medicine treatment of the dialectical treatment of western medicine with conventional therapy in chronic heart failure folder Stasis Syndrome of Qi-Yin Deficiency and Yang Pan-water certification programs effective, user-friendly and worthy of further promotion.
引文
[1]杨景锋,任艳芸.心力衰竭的中医治疗思路.时珍国医国药2007,18,(1):199.
[2]戴闺柱.心力衰竭诊断与治疗研究进展.中华心血管病杂志2003,31(9):641-645.
[3]陈国伟.心力衰竭流行病学特点及变迁.中国社区医师,2003;18(20):12.
[4]黄峻.现代循证心脏病学[M].江苏科学技术出版社,2003;94-124.
[5]王知军,张立功。充血性心力衰竭的现代研究新进展.中国心血管病研究杂志.2006,4(9):708-710.
[6]张琦.素问释义.科学技术文献出版社,1998.
[7]徐润.实用中医内科急症学.北京:北京出版社(第1版),1992. 20
[8]吕光荣.中医心病证治.昆明:云南人民出版社(第1版),1978.
[9]任继学.心衰辨治.中医药学报,1985,1:43.
[10]中华中医药学会内科分会.内科疾病名称规范研究组,中医内科疾病名称规范究.中医古籍出版社,2005.
[11]徐左北.谈中医对心衰的认识.辽宁中医药大学学报.2007,9(2):7-8.
[12]严夏,周文斌,杨志敏.颜德馨教授治疗心衰经验摭拾.实用中医内科杂志.2003,17(6):447.
[13]唐蜀华.中医药治疗充血性心力衰竭的临床体会[J].上海中医药杂志.2003,37(1):23-25.
[14]丁爱国.韩子江辨治充血性心衰的思路和方法[J].辽宁中医杂志.1998,25(5):199-200.
[15]曹雪滨,浦斌红,胡元会.充血性心力衰竭的中医辨证分型特点[J].甘肃中医药大学学报,1999,16(3):13-16.
[16]谭璐芸,安莉萍.谈郭维琴教授辨治心衰经验[J].新疆中医药.2000,18(4):51-52.
[17]吴勉华.充血性心力衰竭中医病机探讨[J].南京中医药大学学报(自然科学版).2001,17(4):206-209.
[18]毛春燕.中医对充血性心力衰竭的认识及治疗对策[J].河北中医.2002,24(11):823-824.
[19]何建成.浅谈充血性心力衰竭中医药治疗[J].甘肃中医.1999,12(4):10-11.
[20]黄平东.中医古籍对心力衰竭的论述探要[J].中医药学刊,2003,21(4): 392-393.
[21]葛鸿庆,赵梁,郝李敏.邓铁涛教授从脾论治慢性充血性心力衰竭之经验[J].上海中医药.2002,36(4):9-10.
[22]李瑞.充血性心力衰竭的中医病机探讨[J].现代中医药,2003,1:13-14.
[23]程丑夫,张炜宁.心衰的中医病证归属浅析[J].山东中医药大学学报,1998,22(2):107-108.
[24]周仲英,金妙文,吴勉华,等.益阴助阳、活血通脉法治疗充血性心力衰竭的临床研究[J].南京中医药大学学报,2000,16.
[25]邵冰.中西医结合治疗慢性肺心病顽固型心衰200例临床分析.北华大学学报(自然科学版)2005,6(4):341-342.
[26]吴同启.鸡鸣散治疗风心病心衰18例临证报道.中医药研究1999,15(5):16-17.
[27]霍根红.谈气血水相关理论与心力衰竭[J].河南中医药学刊,1995,10(4):8.
[28]王庆才.恶性肿瘤从痰论之初探[J].辽宁中医杂志,1996,23(5):209-211.
[29]李琏.李介鸣治疗心力衰竭经验.临症心得.2001,3,42(3):138-139.
[30]焦晓民.中西医结合治疗难治性心衰30例.辽宁中医杂志,2005,32(5):455-456.
[31]朴勇洙,冯大鹏,蔡宏宇.充血性心力衰竭的中医概述[J].中华实用中西医杂志,2003,3(16):479.
[32]黄平东,罗懿明,黄衍寿等.充血性心力衰竭中医证型特征及其演变规律的临床观察[J].中西医结合心脑血管病杂志,2003,1(12):685-686.
[33]马中夫,梁辉东,王友成.心衰病症的中医诠释及治疗[J].辽宁中医杂志,2001,28(2):110.
[34]尹光春,吴焕林.邓铁涛教授调脾护心法治疗心力衰竭经验[J].新中医,2002,34(5):11-12.
[35]马术明.慢性充血性心力衰竭的辨证论治[J].吉林中医药,2004,24(2):6-8.
[36]杨培君.充血性心力衰竭的中医证治概要[J].陕西中医学院学报,2002,25(1):2.
[37]东向前.辨证论治心力衰竭体会[J].天津中医,2000,17(1):47-48.
[38]黄永生.心衰论治[J].湖南中医药导报,2000,6(9):325.
[39]何建成.浅谈充血性心力衰竭中医药治疗[J]甘肃中医,1999,12(4):10-11.
[40]王素琴.心衰的中医辨证论治[J].河北医学,2002,8(3):283-284.
[41]冼绍祥,周凤娇.中医药治疗心力衰竭的临床研究进展.辽宁中医药大学学报,2006,11,8(6):165-167.
[42]连林芳.辩证分型治疗充血性心力衰竭例析[J].实用中医内科杂志,2004,8(4):301-2.
[43]冯国标.略论慢性心衰的辨证论治[J].河南中医药学刊,1998,13(2):6.
[44]刘建民,张忠群,闫振界.中医辨证治疗慢性心力衰竭182例临床观察[J] .国医论坛,2002,17(3):20-21
[45]张瑞华,焦增绵,马丽红.慢性充血性心力衰竭的中医辨证论治[J].中国医药学报,2002,17(7):440-441.
[46]孔庆福,宋树芝,谢学英等.中医辨证施治联合卡托普利治疗急性重症病毒性心肌炎并心力衰竭的临床研究[J].中国中西医结合杂志,2001,21(7):513-515.
[47]李献夷.邓铁涛教育治疗心衰的思路与方法[J].新中医,1995,27(10):6
[48]谢钦达.回阳通痹汤治疗慢性心功能不全.浙江中西医结合杂志,2004(8):465.
[49]杨蕊琳,病证结合论治充血性心力衰竭.贵阳中医学院学报,2003,22(4):36-37.
[50]谢乐.中医分型治疗心力衰竭77例[J].四川中医,2000,20(6):41.
[51]梁金凤.辨证治疗充血性心力衰竭42例[J].陕西中医,1995,16(3):97.
[52]顾炳岐.救心方治疗慢性心力衰竭34例[J].中医药研究,1999,15(2):56.
[53]罗玉国.辨证治疗充血性心衰31例[J].江苏中医,1995,16(1):7.
[54]史小青,中医辨证治疗心力衰竭的思路及方法[J].四川中医,2003,21(6):11-12.
[55]蔺如光.温阳益气活血法治疗慢性心力衰竭32例.江苏中医,2001,22(6):22.
[56]田俊.参附注射液对充血性心力衰竭病人血液流变学的影响及疗效观察.中西医结合心脑血管病杂志,2003,1(6):324.
[57]王智慧等.参附注射滚治疗俊性充血性心力衰竭的疗效观察.中医药学报,1998,26(3):19.
[58]李绍敏,汪小红.黄芪注射液治疗严重充血性心力衰竭疗效及其对QT离散度的影响[J].中西医结合实用临床急救,1998,5(3):123-125.
[59]卢延生.不同剂量黄芪注射液治疗难治性心衰的临床观察[J].江苏中医,2001,22(9):45.
[60]王红梅等.黄芪注射液治疗老年充血性心力衰竭.天津中医,2002,12:21.
[61]黄耀明,沈德方.生脉注射液治疗充血性心力衰竭115例临床分析.哈尔滨医药,2002,22(1):19.
[62]柯双平等.复方丹参注射液治疗肺心病心力衰竭44例疗效观察.九江医学,2000,4:221.
[63]刘庆林等.复方丹参治疗慢性肺心病急性发作72例疗效观察.现代中西医结合杂志,2002,2:108.
[64]艾俊等.黄芪注射液与丹参注射液联合治疗慢性肺心病心衰.现代中西医结合杂志,2001,10(6):525.
[65]陆玲英,参麦注射液合附桂汤治疗肺心病心衰的30例观察[J].黑龙江中医药,2000,6:26-27.
[66]杨文明,周宜轩.参麦注射液治疗心力衰竭疗效观察[J].中西医结合实用临床急救,1997,4(7):295-297.
[67]苏慧敏.芪苈强心胶囊对慢性充血性心力衰竭病人生活质量的影响.中西医结合心脑血管病杂志,2007,10(5):719.
[68]杨硕.张艳教授治疗慢性充血性心力衰竭经验撷菁.CHINESE ARCHIVES OF TRADITION CHINESE MEDICINE.Vol. 25 No.3 Mar.2007:441-442.
[69]上海市心力衰竭调查协作组.上海市1980、1990、2000年心力衰竭住院患者流行病学及治疗状况调查[J].中华心血管病杂志,2002,30(5):24-26.
[70]张伟.充血性心力衰竭的临床治疗探讨.社区医学杂志2007,5(2)(下):53.
[71]黄创.充血性心力衰竭的治疗进展.Anthology of Medicine,Apri1 2006,Vol125,No12:338-339.
[72]翟淑波.充血性心力衰竭发病机制的研究进展.J Clin Pediatr Vol.24 No.10 October 2006:851-853.
[73]赵凤德.B型脑钠肽在心血管病中的临床价值.IntJ Lab Med ,October 2006,Vol.27 ,No.10.
[74]乔薇,张小平,钱端,郑知刚.B型利钠肽在心力衰竭诊断和心功能评估中的临床价值.Journal of China- Japan Friendship Hospital,2007 Jun,Vol.21.No.3:141-143.
[75]刘芦姗,秦俭.B型利钠肽的研究进展.内科急危重症杂志,2007,13(1):41-43. [76 ]陈协兴,洪华山,王一波,江琼,董现锋,陈良龙.慢性心力衰竭患者血清脑利钠肽水平的变化及其临床意义.中国临床药理学与治疗学2003 Dec;8 6:631-634.
[77]张昀晟.脑利钠肽水平与心力衰竭的相关性.中国误诊学杂志2005,10,5(14).
[78]吴少琴,卢益中.B型利钠肽水平与心力衰竭的关系.Journal of Chinese Physician,July,2006,Vol 8,No7:984-985.
[79]潘丽丽,王瑞英,张玲,鹿金凤.血清肌钙蛋白é测定与心力衰竭预后的临床研究.临床医药实践杂志.2006,9,15(9).
[80]邹操.钙循环与心力衰竭.Adv Cardiovasc Dis,March 2007,Vol.28,No. 2:266-269.
[81]赵文蕊.心力衰竭的研究进展.青海医药杂志2004,34(7).
[82]黄创.充血性心力衰竭的治疗进展.Anthology of Medicine,Apr12006,V ol125,No12:338-340.
[83]纪宝华.心力衰竭的治疗与研究进展.Clinical Misdiagnosis &Mistherapy October 2000,Vol 13,No.5:348-351.
[84]杨玉雄.螺内酯治疗充血性心力衰竭的疗效观察.基层医学论坛2006,10,(5)A版:425-426.
[85]李春善,刘桂莲,王安娜.β-受体阻滞剂治疗心力衰竭的疗效观察.吉林医学2007,1,28(1):62-63.
[86]吴彬.美托洛尔治疗充血性心力衰竭60例临床观察.JPMT, Ap ril. 2007,Vol.14,No.12(Issued Every Ten Days):1593-1594.
[87]胡香金.美托洛尔治疗慢性心力衰竭98例观察.基层医学论坛2007,11,(6)B版:496-497.
[88]柯元南.慢性心力衰竭诊治新进展.中国全科医学.2007,3,10,(6):433-434.
[89] Trifonov IR.Efficacy of an aldosterone receptor blocker eplerenone in high risk survivor so facutemy ocardial in farction with signs of heart failure :result of PHESUS.kardiologiia ,2003;43:71-72.
[90]贾公孚.临床药物新用联用大全.北京:人民卫生出版社,1999.99.
[91]杜媛媛.纳洛酮治疗幼儿充血性心衰疗效观察.中西医结合心脑血管病杂志,2004,7(2):434.
[92]张友龙.纳洛酮对小猪缺氧模型的心肌保护作用.当代医药卫生,2005,21 (16):2100-2102.
[93]李运伟.纳洛酮治疗顽固性心衰的临床观察.Central Plains Medical Journal Aug.2006,Vol 33,No.15:76.
[94]罗彩云,常见抗心力衰竭药物副反应的观察与护理.南方护理学报,2003,6,10(3):58-59.
[95]华琦.慢性心力衰竭患者药物治疗的要点.Chinese Circulation,June,2006,Vol.21No.3(SerialNo.139):236.
[96]皮大茂.尼莫地平致不良反应78例统计分析[J].医药导报,2005,12:104-106.
[97]王振纲.抗高血压药应用现状及评价[J].中国医院用药评价与分析,2001,1 (2):79.
[98]赵丽萍.老年人心血管药物的合理使用.实用医技杂志2006,13(13)(半月刊):2252-2253.
[99]陈安.低钠与限钠对难治性心力衰竭的影响.中国心血管病研究杂志,2005,3:46.
[100]金兰.慢性心力衰竭的药物治疗.中国实用内科杂志,2004,1:11.
[101]新里拓郎等.慢性心力衰竭的温热疗法.日本医学介绍2007,28(6):241-243.
[102]赵永,苏东升,侯素霞.心衰合剂治疗充血性心力衰竭12例.山东中医药大学学报,2001,25(l):27-29.
[103]孙长春,中西医结合治疗慢性心功能不全疗效观察.辽宁中医杂志,2002(7):420-421.
[104]阳育昌.应用心血通注射液治疗充血性心力衰竭的临床观察.广西医学,2002,24(7):110-111.
[105]司巧梅.复方丹参联合酚妥拉明治疗肺心病心衰临床观察.现代中西医结合杂志,2003(12):2548.
[106]万启南等.强心胶囊治疗充血性心力衰竭96例临床观察.中国中医药信息杂志,2003(11):10.
[107]邓德明,顾充,苏维广,等.心宁煎剂治疗充血性心力衰竭50例临床研究[J].中医杂志,2002,43(8):593-594.
[108]杨丁友,徐浩,段学忠,等.慢衰灵口服液对心肾阳虚型充血性心力衰竭患者细胞因子的干预作用[J].中国中西医结合杂志,2002,22(12):899-901.
[109]朱德礼,静文英.中西医结合治疗充血性心力衰竭临床分析.中国中医药信息杂志,2001;8(2):65.
[110]杨俊英,赵玉环.中西医结合治疗慢性心衰疗效观察.河北中医,2001;23(20):132.
[111]姬同超.中西医结合治疗慢性心力衰竭50例.光明中医,2008;23(7):459.
[112]宋立人,洪恂,丁绪亮,等.现代中药学大辞典(上册)[M].北京:人民卫生出版社,2001:364-443.
[113]雷载权,张廷模.中华临床中药学(下卷)[M].北京:人民卫生出版社, 1998:972-975.
[114]王晓霞,董静,程广清.生脉散加味治疗老年慢性心力衰竭136例疗效观察.山东中医杂志2007,9(26):603.
[115]吴以岭.主编.络病学[M]北京:中国科学技术出版社,2004:283-285.
[116]何居仁,马丹军.黄芪注射液治疗充血性心力衰竭作用机理探讨[J].上海医药,2000,21(1):25-26.
[117]杨孟考.单味葶苈子治疗顽固性心衰23例[J].中国社区医师,2002,18 (20):40.
[118]李刚毅,苏廷秀.治疗充血性心功能不全及葶苈子应用之管见[J].实用中医内科杂志,1995,9(3):18-19.
[119]吴以岭.“络脉—血管系统病”新概念及其治疗探讨[J].疑难病杂志,2005,4(5):285-287.
[120] Mueller T,Gegenhuber A,Poelz W ,et a1.Biochemical diagnosis of impaired left ventricular ejection fraction -comparison of the diagnostic accuracy of brain natriuretic peptide(BNP)and aminoterminal proBNP(NT-proBNP).Clin Chem Lab Med,2004,42:159-163.
[121] Cosin AJ,Hernandiz MA,Diez G JL,et a1.Value of NTproBNP con.centration in an out—of-hospital aduh population[J].Rev Esp Cardiol 2003.56:236—244
[122] Davis M,E,Richards G, et al.Plasma brain natriuretic peptide in assessment of acute dyspnoea [J]. Lancet,1994,343(8895):440-444.
[123] Morrison LK, Harrison A,Krishnaswamy P,et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coll Cardiol,2002,39(2):202-209.
[124] Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction [J]. Am Heart J,2001,141(3):367-374.
[125]叶任高,陆再英主编.内科学.第6版.北京:人民卫生出版社,2006.167-272.
[126] MayerSA.Comparison of B–type natriure tic pep tide levlsin patients with Heart failure with versus without mitral regurgitation. AmJ Cardiol, 2004,93: 1002-1006.
[127] Doust JA, Pietrzak E,Dobson A, et al. How well doesB2type natriuretic pep tidep redict death and cardiac events in patientswith heart failure: systematic review[J]. BMJ,2005,330:625.
[2]戴闺柱.心力衰竭诊断与治疗研究进展.中华心血管病杂志2003,31(9):641-645.
[3]陈国伟.心力衰竭流行病学特点及变迁.中国社区医师,2003;18(20):12.
[4]黄峻.现代循证心脏病学[M].江苏科学技术出版社,2003;94-124.
[5]王知军,张立功。充血性心力衰竭的现代研究新进展.中国心血管病研究杂志.2006,4(9):708-710.
[6]张琦.素问释义.科学技术文献出版社,1998.
[7]徐润.实用中医内科急症学.北京:北京出版社(第1版),1992. 20
[8]吕光荣.中医心病证治.昆明:云南人民出版社(第1版),1978.
[9]任继学.心衰辨治.中医药学报,1985,1:43.
[10]中华中医药学会内科分会.内科疾病名称规范研究组,中医内科疾病名称规范究.中医古籍出版社,2005.
[11]徐左北.谈中医对心衰的认识.辽宁中医药大学学报.2007,9(2):7-8.
[12]严夏,周文斌,杨志敏.颜德馨教授治疗心衰经验摭拾.实用中医内科杂志.2003,17(6):447.
[13]唐蜀华.中医药治疗充血性心力衰竭的临床体会[J].上海中医药杂志.2003,37(1):23-25.
[14]丁爱国.韩子江辨治充血性心衰的思路和方法[J].辽宁中医杂志.1998,25(5):199-200.
[15]曹雪滨,浦斌红,胡元会.充血性心力衰竭的中医辨证分型特点[J].甘肃中医药大学学报,1999,16(3):13-16.
[16]谭璐芸,安莉萍.谈郭维琴教授辨治心衰经验[J].新疆中医药.2000,18(4):51-52.
[17]吴勉华.充血性心力衰竭中医病机探讨[J].南京中医药大学学报(自然科学版).2001,17(4):206-209.
[18]毛春燕.中医对充血性心力衰竭的认识及治疗对策[J].河北中医.2002,24(11):823-824.
[19]何建成.浅谈充血性心力衰竭中医药治疗[J].甘肃中医.1999,12(4):10-11.
[20]黄平东.中医古籍对心力衰竭的论述探要[J].中医药学刊,2003,21(4): 392-393.
[21]葛鸿庆,赵梁,郝李敏.邓铁涛教授从脾论治慢性充血性心力衰竭之经验[J].上海中医药.2002,36(4):9-10.
[22]李瑞.充血性心力衰竭的中医病机探讨[J].现代中医药,2003,1:13-14.
[23]程丑夫,张炜宁.心衰的中医病证归属浅析[J].山东中医药大学学报,1998,22(2):107-108.
[24]周仲英,金妙文,吴勉华,等.益阴助阳、活血通脉法治疗充血性心力衰竭的临床研究[J].南京中医药大学学报,2000,16.
[25]邵冰.中西医结合治疗慢性肺心病顽固型心衰200例临床分析.北华大学学报(自然科学版)2005,6(4):341-342.
[26]吴同启.鸡鸣散治疗风心病心衰18例临证报道.中医药研究1999,15(5):16-17.
[27]霍根红.谈气血水相关理论与心力衰竭[J].河南中医药学刊,1995,10(4):8.
[28]王庆才.恶性肿瘤从痰论之初探[J].辽宁中医杂志,1996,23(5):209-211.
[29]李琏.李介鸣治疗心力衰竭经验.临症心得.2001,3,42(3):138-139.
[30]焦晓民.中西医结合治疗难治性心衰30例.辽宁中医杂志,2005,32(5):455-456.
[31]朴勇洙,冯大鹏,蔡宏宇.充血性心力衰竭的中医概述[J].中华实用中西医杂志,2003,3(16):479.
[32]黄平东,罗懿明,黄衍寿等.充血性心力衰竭中医证型特征及其演变规律的临床观察[J].中西医结合心脑血管病杂志,2003,1(12):685-686.
[33]马中夫,梁辉东,王友成.心衰病症的中医诠释及治疗[J].辽宁中医杂志,2001,28(2):110.
[34]尹光春,吴焕林.邓铁涛教授调脾护心法治疗心力衰竭经验[J].新中医,2002,34(5):11-12.
[35]马术明.慢性充血性心力衰竭的辨证论治[J].吉林中医药,2004,24(2):6-8.
[36]杨培君.充血性心力衰竭的中医证治概要[J].陕西中医学院学报,2002,25(1):2.
[37]东向前.辨证论治心力衰竭体会[J].天津中医,2000,17(1):47-48.
[38]黄永生.心衰论治[J].湖南中医药导报,2000,6(9):325.
[39]何建成.浅谈充血性心力衰竭中医药治疗[J]甘肃中医,1999,12(4):10-11.
[40]王素琴.心衰的中医辨证论治[J].河北医学,2002,8(3):283-284.
[41]冼绍祥,周凤娇.中医药治疗心力衰竭的临床研究进展.辽宁中医药大学学报,2006,11,8(6):165-167.
[42]连林芳.辩证分型治疗充血性心力衰竭例析[J].实用中医内科杂志,2004,8(4):301-2.
[43]冯国标.略论慢性心衰的辨证论治[J].河南中医药学刊,1998,13(2):6.
[44]刘建民,张忠群,闫振界.中医辨证治疗慢性心力衰竭182例临床观察[J] .国医论坛,2002,17(3):20-21
[45]张瑞华,焦增绵,马丽红.慢性充血性心力衰竭的中医辨证论治[J].中国医药学报,2002,17(7):440-441.
[46]孔庆福,宋树芝,谢学英等.中医辨证施治联合卡托普利治疗急性重症病毒性心肌炎并心力衰竭的临床研究[J].中国中西医结合杂志,2001,21(7):513-515.
[47]李献夷.邓铁涛教育治疗心衰的思路与方法[J].新中医,1995,27(10):6
[48]谢钦达.回阳通痹汤治疗慢性心功能不全.浙江中西医结合杂志,2004(8):465.
[49]杨蕊琳,病证结合论治充血性心力衰竭.贵阳中医学院学报,2003,22(4):36-37.
[50]谢乐.中医分型治疗心力衰竭77例[J].四川中医,2000,20(6):41.
[51]梁金凤.辨证治疗充血性心力衰竭42例[J].陕西中医,1995,16(3):97.
[52]顾炳岐.救心方治疗慢性心力衰竭34例[J].中医药研究,1999,15(2):56.
[53]罗玉国.辨证治疗充血性心衰31例[J].江苏中医,1995,16(1):7.
[54]史小青,中医辨证治疗心力衰竭的思路及方法[J].四川中医,2003,21(6):11-12.
[55]蔺如光.温阳益气活血法治疗慢性心力衰竭32例.江苏中医,2001,22(6):22.
[56]田俊.参附注射液对充血性心力衰竭病人血液流变学的影响及疗效观察.中西医结合心脑血管病杂志,2003,1(6):324.
[57]王智慧等.参附注射滚治疗俊性充血性心力衰竭的疗效观察.中医药学报,1998,26(3):19.
[58]李绍敏,汪小红.黄芪注射液治疗严重充血性心力衰竭疗效及其对QT离散度的影响[J].中西医结合实用临床急救,1998,5(3):123-125.
[59]卢延生.不同剂量黄芪注射液治疗难治性心衰的临床观察[J].江苏中医,2001,22(9):45.
[60]王红梅等.黄芪注射液治疗老年充血性心力衰竭.天津中医,2002,12:21.
[61]黄耀明,沈德方.生脉注射液治疗充血性心力衰竭115例临床分析.哈尔滨医药,2002,22(1):19.
[62]柯双平等.复方丹参注射液治疗肺心病心力衰竭44例疗效观察.九江医学,2000,4:221.
[63]刘庆林等.复方丹参治疗慢性肺心病急性发作72例疗效观察.现代中西医结合杂志,2002,2:108.
[64]艾俊等.黄芪注射液与丹参注射液联合治疗慢性肺心病心衰.现代中西医结合杂志,2001,10(6):525.
[65]陆玲英,参麦注射液合附桂汤治疗肺心病心衰的30例观察[J].黑龙江中医药,2000,6:26-27.
[66]杨文明,周宜轩.参麦注射液治疗心力衰竭疗效观察[J].中西医结合实用临床急救,1997,4(7):295-297.
[67]苏慧敏.芪苈强心胶囊对慢性充血性心力衰竭病人生活质量的影响.中西医结合心脑血管病杂志,2007,10(5):719.
[68]杨硕.张艳教授治疗慢性充血性心力衰竭经验撷菁.CHINESE ARCHIVES OF TRADITION CHINESE MEDICINE.Vol. 25 No.3 Mar.2007:441-442.
[69]上海市心力衰竭调查协作组.上海市1980、1990、2000年心力衰竭住院患者流行病学及治疗状况调查[J].中华心血管病杂志,2002,30(5):24-26.
[70]张伟.充血性心力衰竭的临床治疗探讨.社区医学杂志2007,5(2)(下):53.
[71]黄创.充血性心力衰竭的治疗进展.Anthology of Medicine,Apri1 2006,Vol125,No12:338-339.
[72]翟淑波.充血性心力衰竭发病机制的研究进展.J Clin Pediatr Vol.24 No.10 October 2006:851-853.
[73]赵凤德.B型脑钠肽在心血管病中的临床价值.IntJ Lab Med ,October 2006,Vol.27 ,No.10.
[74]乔薇,张小平,钱端,郑知刚.B型利钠肽在心力衰竭诊断和心功能评估中的临床价值.Journal of China- Japan Friendship Hospital,2007 Jun,Vol.21.No.3:141-143.
[75]刘芦姗,秦俭.B型利钠肽的研究进展.内科急危重症杂志,2007,13(1):41-43. [76 ]陈协兴,洪华山,王一波,江琼,董现锋,陈良龙.慢性心力衰竭患者血清脑利钠肽水平的变化及其临床意义.中国临床药理学与治疗学2003 Dec;8 6:631-634.
[77]张昀晟.脑利钠肽水平与心力衰竭的相关性.中国误诊学杂志2005,10,5(14).
[78]吴少琴,卢益中.B型利钠肽水平与心力衰竭的关系.Journal of Chinese Physician,July,2006,Vol 8,No7:984-985.
[79]潘丽丽,王瑞英,张玲,鹿金凤.血清肌钙蛋白é测定与心力衰竭预后的临床研究.临床医药实践杂志.2006,9,15(9).
[80]邹操.钙循环与心力衰竭.Adv Cardiovasc Dis,March 2007,Vol.28,No. 2:266-269.
[81]赵文蕊.心力衰竭的研究进展.青海医药杂志2004,34(7).
[82]黄创.充血性心力衰竭的治疗进展.Anthology of Medicine,Apr12006,V ol125,No12:338-340.
[83]纪宝华.心力衰竭的治疗与研究进展.Clinical Misdiagnosis &Mistherapy October 2000,Vol 13,No.5:348-351.
[84]杨玉雄.螺内酯治疗充血性心力衰竭的疗效观察.基层医学论坛2006,10,(5)A版:425-426.
[85]李春善,刘桂莲,王安娜.β-受体阻滞剂治疗心力衰竭的疗效观察.吉林医学2007,1,28(1):62-63.
[86]吴彬.美托洛尔治疗充血性心力衰竭60例临床观察.JPMT, Ap ril. 2007,Vol.14,No.12(Issued Every Ten Days):1593-1594.
[87]胡香金.美托洛尔治疗慢性心力衰竭98例观察.基层医学论坛2007,11,(6)B版:496-497.
[88]柯元南.慢性心力衰竭诊治新进展.中国全科医学.2007,3,10,(6):433-434.
[89] Trifonov IR.Efficacy of an aldosterone receptor blocker eplerenone in high risk survivor so facutemy ocardial in farction with signs of heart failure :result of PHESUS.kardiologiia ,2003;43:71-72.
[90]贾公孚.临床药物新用联用大全.北京:人民卫生出版社,1999.99.
[91]杜媛媛.纳洛酮治疗幼儿充血性心衰疗效观察.中西医结合心脑血管病杂志,2004,7(2):434.
[92]张友龙.纳洛酮对小猪缺氧模型的心肌保护作用.当代医药卫生,2005,21 (16):2100-2102.
[93]李运伟.纳洛酮治疗顽固性心衰的临床观察.Central Plains Medical Journal Aug.2006,Vol 33,No.15:76.
[94]罗彩云,常见抗心力衰竭药物副反应的观察与护理.南方护理学报,2003,6,10(3):58-59.
[95]华琦.慢性心力衰竭患者药物治疗的要点.Chinese Circulation,June,2006,Vol.21No.3(SerialNo.139):236.
[96]皮大茂.尼莫地平致不良反应78例统计分析[J].医药导报,2005,12:104-106.
[97]王振纲.抗高血压药应用现状及评价[J].中国医院用药评价与分析,2001,1 (2):79.
[98]赵丽萍.老年人心血管药物的合理使用.实用医技杂志2006,13(13)(半月刊):2252-2253.
[99]陈安.低钠与限钠对难治性心力衰竭的影响.中国心血管病研究杂志,2005,3:46.
[100]金兰.慢性心力衰竭的药物治疗.中国实用内科杂志,2004,1:11.
[101]新里拓郎等.慢性心力衰竭的温热疗法.日本医学介绍2007,28(6):241-243.
[102]赵永,苏东升,侯素霞.心衰合剂治疗充血性心力衰竭12例.山东中医药大学学报,2001,25(l):27-29.
[103]孙长春,中西医结合治疗慢性心功能不全疗效观察.辽宁中医杂志,2002(7):420-421.
[104]阳育昌.应用心血通注射液治疗充血性心力衰竭的临床观察.广西医学,2002,24(7):110-111.
[105]司巧梅.复方丹参联合酚妥拉明治疗肺心病心衰临床观察.现代中西医结合杂志,2003(12):2548.
[106]万启南等.强心胶囊治疗充血性心力衰竭96例临床观察.中国中医药信息杂志,2003(11):10.
[107]邓德明,顾充,苏维广,等.心宁煎剂治疗充血性心力衰竭50例临床研究[J].中医杂志,2002,43(8):593-594.
[108]杨丁友,徐浩,段学忠,等.慢衰灵口服液对心肾阳虚型充血性心力衰竭患者细胞因子的干预作用[J].中国中西医结合杂志,2002,22(12):899-901.
[109]朱德礼,静文英.中西医结合治疗充血性心力衰竭临床分析.中国中医药信息杂志,2001;8(2):65.
[110]杨俊英,赵玉环.中西医结合治疗慢性心衰疗效观察.河北中医,2001;23(20):132.
[111]姬同超.中西医结合治疗慢性心力衰竭50例.光明中医,2008;23(7):459.
[112]宋立人,洪恂,丁绪亮,等.现代中药学大辞典(上册)[M].北京:人民卫生出版社,2001:364-443.
[113]雷载权,张廷模.中华临床中药学(下卷)[M].北京:人民卫生出版社, 1998:972-975.
[114]王晓霞,董静,程广清.生脉散加味治疗老年慢性心力衰竭136例疗效观察.山东中医杂志2007,9(26):603.
[115]吴以岭.主编.络病学[M]北京:中国科学技术出版社,2004:283-285.
[116]何居仁,马丹军.黄芪注射液治疗充血性心力衰竭作用机理探讨[J].上海医药,2000,21(1):25-26.
[117]杨孟考.单味葶苈子治疗顽固性心衰23例[J].中国社区医师,2002,18 (20):40.
[118]李刚毅,苏廷秀.治疗充血性心功能不全及葶苈子应用之管见[J].实用中医内科杂志,1995,9(3):18-19.
[119]吴以岭.“络脉—血管系统病”新概念及其治疗探讨[J].疑难病杂志,2005,4(5):285-287.
[120] Mueller T,Gegenhuber A,Poelz W ,et a1.Biochemical diagnosis of impaired left ventricular ejection fraction -comparison of the diagnostic accuracy of brain natriuretic peptide(BNP)and aminoterminal proBNP(NT-proBNP).Clin Chem Lab Med,2004,42:159-163.
[121] Cosin AJ,Hernandiz MA,Diez G JL,et a1.Value of NTproBNP con.centration in an out—of-hospital aduh population[J].Rev Esp Cardiol 2003.56:236—244
[122] Davis M,E,Richards G, et al.Plasma brain natriuretic peptide in assessment of acute dyspnoea [J]. Lancet,1994,343(8895):440-444.
[123] Morrison LK, Harrison A,Krishnaswamy P,et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coll Cardiol,2002,39(2):202-209.
[124] Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction [J]. Am Heart J,2001,141(3):367-374.
[125]叶任高,陆再英主编.内科学.第6版.北京:人民卫生出版社,2006.167-272.
[126] MayerSA.Comparison of B–type natriure tic pep tide levlsin patients with Heart failure with versus without mitral regurgitation. AmJ Cardiol, 2004,93: 1002-1006.
[127] Doust JA, Pietrzak E,Dobson A, et al. How well doesB2type natriuretic pep tidep redict death and cardiac events in patientswith heart failure: systematic review[J]. BMJ,2005,330:625.